浏览与细胞增殖紊乱、肿瘤学研究及抗增殖筛选相关的疾病导向型小分子。利用本页面围绕生长调控生物学、疾病机制及后续验证工作流程构建化合物集合。
细胞增殖性疾病
按类别选购
肠易激综合征(DOID:9778) irritable bowel syndrome (DOID:9778)
2,379多囊卵巢综合征(DOID:11612) polycystic ovary syndrome (DOID:11612)
2,022慢性疲劳综合征(DOID:8544) chronic fatigue syndrome (DOID:8544)
965努南综合征(DOID:3490) Noonan syndrome (DOID:3490)
81婴儿猝死综合征(DOID:9007) sudden infant death syndrome (DOID:9007)
41贝克威思-威德曼综合征(DOID:5572) Beckwith-Wiedemann syndrome (DOID:5572)
21心面皮肤综合征(DOID:0060233) cardiofaciocutaneous syndrome (DOID:0060233)
6Pitt-Hopkins综合征(DOID:0060488) Pitt-Hopkins syndrome (DOID:0060488)
229奥利尔病(DOID:4624) Ollier disease (DOID:4624)
7歌舞伎综合征(DOID:0060473) Kabuki syndrome (DOID:0060473)
126罗宾诺综合征(DOID:0060254) Robinow syndrome (DOID:0060254)
498CHARGE综合征(DOID:0050834) CHARGE syndrome (DOID:0050834)
44马夫奇综合征(DOID:0060221) Maffucci syndrome (DOID:0060221)
0施瓦赫曼-戴蒙德综合征(DOID:0060479) Shwachman-Diamond syndrome (DOID:0060479)
129高安氏动脉炎 (DOID:2508) Takayasu's arteritis (DOID:2508)
491卓-艾综合征(DOID:0050782) Zollinger-Ellison syndrome (DOID:0050782)
61Klippel-Trenaunay 综合征 (DOID:2926) Klippel-Trenaunay syndrome (DOID:2926)
8莫瓦特-威尔逊综合征(DOID:0060485) Mowat-Wilson syndrome (DOID:0060485)
65巴雷特瑟-温特综合征(DOID:0060229) Baraitser-Winter syndrome (DOID:0060229)
0EAST综合征(DOID:0060484) EAST syndrome (DOID:0060484)
167艾卡迪综合征(DOID:8461) Aicardi syndrome (DOID:8461)
47VACTERL综合征(DOID:14679) VACTERL association (DOID:14679)
11库伦·德弗里斯综合征 (DOID:0050880) Koolen de Vries syndrome (DOID:0050880)
24帕廷顿综合征(DOID:14744) Partington syndrome (DOID:14744)
22下颌面骨发育不全伴脱发(DOID:0060365) mandibulofacial dysostosis with alopecia (DOID:0060365)
81眼耳综合征 (DOID:0060482) oculoauricular syndrome (DOID:0060482)
30戈德堡-施普林岑综合征(DOID:0060481) Goldberg-Shprintzen syndrome (DOID:0060481)
22Lown-Ganong-Levine 综合征 (DOID:13087) Lown-Ganong-Levine syndrome (DOID:13087)
10Kleefstra 综合征 (DOID:0060352) Kleefstra syndrome (DOID:0060352)
23致死性先天性挛缩综合征(DOID:0060558) lethal congenital contracture syndrome (DOID:0060558)
10正中弓状韧带综合征(DOID:9892) median arcuate ligament syndrome (DOID:9892)
26产品列表
-
4-[4-[3-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenyl]morpholine化合物 CID: 60182393Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: H608691查看产品价格与包装
技术标识符
- IUPAC名称
- 4-[4-[3-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenyl]morpholine
- SMILES
- O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
- InChIKey
- WCDLCPLAAKUJNY-UHFFFAOYSA-N
- InChI
- 1S/C19H18N6O/c1-3-17(24-5-7-26-8-6-24)4-2-14(1)16-9-20-19-18(12-23-25(19)13-16)15-10-21-22-11-15/h1-4,9-13H,5-8H2,(H,21,22)
-
4-[6-[4-(4-methylpiperazin-1-yl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline化合物 CID: 60182364Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M608713查看产品价格与包装
技术标识符
- IUPAC名称
- 4-[6-[4-(4-methylpiperazin-1-yl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
- SMILES
- CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
- InChIKey
- XBGWAKUQSRNWMA-UHFFFAOYSA-N
- InChI
- 1S/C26H24N6/c1-30-12-14-31(15-13-30)21-8-6-19(7-9-21)20-16-28-26-24(17-29-32(26)18-20)22-10-11-27-25-5-3-2-4-23(22)25/h2-11,16-18H,12-15H2,1H3
-
4-amino-6-{[(1S)-1-{3-methyl-6-[3-({4-[methyl(2-methylpropyl)amino]piperidin-1-yl}methyl)phenyl]-5-oxo-5H-[1,3]thiazolo[3,2-a]pyridin-7-yl}ethyl]amino}pyrimidine-5-carbonitrile化合物 CID: 134611885Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: A608912查看产品价格与包装
技术标识符
- IUPAC名称
- 4-amino-6-{[(1S)-1-{3-methyl-6-[3-({4-[methyl(2-methylpropyl)amino]piperidin-1-yl}methyl)phenyl]-5-oxo-5H-[1,3]thiazolo[3,2-a]pyridin-7-yl}ethyl]amino}pyrimidine-5-carbonitrile
- SMILES
- N#Cc1c(ncnc1N)N[C@H](c1cc2scc(n2c(=O)c1c1cccc(c1)CN1CCC(CC1)N(CC(C)C)C)C)C
- InChIKey
- ZUQSHQGUCXJKSV-QFIPXVFZSA-N
- InChI
- 显示更多
-
4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide化合物 CID: 59174579Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: F608612查看产品价格与包装
技术标识符
- IUPAC名称
- 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide
- SMILES
- C=CC(=O)Nc1cccc(c1)Nc1nc(ncc1F)Nc1ccc(cc1)Oc1ccnc(c1)C(=O)NC
- InChIKey
- VVLHQJDAUIPZFH-UHFFFAOYSA-N
- InChI
- 1S/C26H22FN7O3/c1-3-23(35)31-17-5-4-6-18(13-17)32-24-21(27)15-30-26(34-24)33-16-7-9-19(10-8-16)37-20-11-12-29-22(14-20)25(36)28-2/h3-15H,1H2,2H3,(H,28,36)(H,31,35)(H2,30,32,33,34)
-
4-arylphthalazin-1(2H)-3,4-Di-F化合物 CID: 56835134Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: A607182查看产品价格与包装
技术标识符
- IUPAC名称
- N-[3-(1-{3-[4-(3,4-difluorophenyl)-1-oxo-1,2-dihydrophthalazin-2-yl]propyl}piperidin-4-yl)phenyl]acetamide
- SMILES
- CC(=O)Nc1cccc(c1)C1CCN(CC1)CCCn1nc(c2ccc(c(c2)F)F)c2c(c1=O)cccc2
- InChIKey
- YVVMAGRTTSOPEO-UHFFFAOYSA-N
- InChI
- 1S/C30H30F2N4O2/c1-20(37)33-24-7-4-6-22(18-24)21-12-16-35(17-13-21)14-5-15-36-30(38)26-9-3-2-8-25(26)29(34-36)23-10-11-27(31)28(32)19-23/h2-4,6-11,18-19,21H,5,12-17H2,1H3,(H,33,37)
-
4-[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]butyl 5-[[3-[(S)-[[(3R)-1-azabicyclo[2.2.2]octan-3-yl]oxycarbonylamino]-phenylmethyl]phenoxy]methyl]-1-methylpyrazole-3-carboxylate化合物 CID: 90200922Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: R608524查看产品价格与包装
技术标识符
- IUPAC名称
- 4-[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]butyl 5-[[3-[(S)-[[(3R)-1-azabicyclo[2.2.2]octan-3-yl]oxycarbonylamino]-phenylmethyl]phenoxy]methyl]-1-methylpyrazole-3-carboxylate
- SMILES
- O=C(O[C@@H]1C2CCN(CC2)C1)N[C@@H](c1ccccc1)c1cc(OCc2cc(C(=O)OCCCCNC[C@H](O)c3c4ccc(=O)[nH]c4c(O)cc3)nn2C)ccc1
- InChIKey
- YWSIONULMMKTSJ-UZGNFBRWSA-N
- InChI
- 显示更多
-
4-methoxy-3-[2-[3-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyridin-4-yl]benzonitrile化合物 CID: 71540619Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M609349查看产品价格与包装
技术标识符
- IUPAC名称
- 4-methoxy-3-[2-[3-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyridin-4-yl]benzonitrile
- SMILES
- COc1cc(ccc1N1CCN(CC1)C)Nc1nccc(c1)c1cc(C#N)ccc1OC
- InChIKey
- GOMSKBLQVUFHHS-UHFFFAOYSA-N
- InChI
- 1S/C25H27N5O2/c1-29-10-12-30(13-11-29)22-6-5-20(16-24(22)32-3)28-25-15-19(8-9-27-25)21-14-18(17-26)4-7-23(21)31-2/h4-9,14-16H,10-13H2,1-3H3,(H,27,28)
-
6-(4-chlorophenyl)-3-[6-(piperidin-1-ylmethyl)naphthalen-2-yl]thieno[2,3-e]pyrimidin-4-one化合物 CID: 11994411Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C608790查看产品价格与包装
技术标识符
- IUPAC名称
- 6-(4-chlorophenyl)-3-[6-(piperidin-1-ylmethyl)naphthalen-2-yl]thieno[2,3-e]pyrimidin-4-one
- SMILES
- Clc1ccc(cc1)c1cc2c(s1)c(=O)n(cn2)c1ccc2c(c1)ccc(c2)CN1CCCCC1
- InChIKey
- FJPBPFUKHDZYIJ-UHFFFAOYSA-N
- InChI
- 1S/C28H24ClN3OS/c29-23-9-6-20(7-10-23)26-16-25-27(34-26)28(33)32(18-30-25)24-11-8-21-14-19(4-5-22(21)15-24)17-31-12-2-1-3-13-31/h4-11,14-16,18H,1-3,12-13,17H2
-
6-(4,6-Dimorpholino-1,3,5-triazin-2-yl)benzo[d]oxazol-2-amine化合物 CID: 164886635Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609025查看产品价格与包装
技术标识符
- IUPAC名称
- 6-(4,6-Dimorpholino-1,3,5-triazin-2-yl)benzo[d]oxazol-2-amine
- SMILES
- Nc1nc2cc(c3nc(N4CCOCC4)nc(N4CCOCC4)n3)ccc2o1
- InChIKey
- LOQNSAZUXOBMAX-UHFFFAOYSA-N
- InChI
- 1S/C18H21N7O3/c19-16-20-13-11-12(1-2-14(13)28-16)15-21-17(24-3-7-26-8-4-24)23-18(22-15)25-5-9-27-10-6-25/h1-2,11H,3-10H2,(H2,19,20)
-
5-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]-2-(furan-3-yl)pyridin-3-yl}-3-methyl-2H-indazole化合物 CID: 46225540Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: S608875查看产品价格与包装
技术标识符
- IUPAC名称
- 5-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]-2-(furan-3-yl)pyridin-3-yl}-3-methyl-2H-indazole
- SMILES
- N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
- InChIKey
- XONRTPBYDAFIRW-NRFANRHFSA-N
- InChI
- 1S/C28H25N5O2/c1-17-24-11-18(6-7-27(24)33-32-17)25-12-22(14-31-28(25)19-8-9-34-15-19)35-16-21(29)10-20-13-30-26-5-3-2-4-23(20)26/h2-9,11-15,21,30H,10,16,29H2,1H3,(H,32,33)/t21-/m0/s1
-
6-(p-Tolyl)-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-4-amine化合物 CID: 137321167Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: P609381查看产品价格与包装
技术标识符
- IUPAC名称
- 6-(p-Tolyl)-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-4-amine
- SMILES
- COc1cc(cc(c1OC)OC)Nc1ncnc2c1sc(c2)c1ccc(cc1)C
- InChIKey
- IXKCNJIWRNIRNO-UHFFFAOYSA-N
- InChI
- 1S/C22H21N3O3S/c1-13-5-7-14(8-6-13)19-11-16-21(29-19)22(24-12-23-16)25-15-9-17(26-2)20(28-4)18(10-15)27-3/h5-12H,1-4H3,(H,23,24,25)
-
6-[4-[(6-chloroimidazo[1,2-a]pyridin-2-yl)methyl]piperazin-1-yl]pyridine-3-carbonitrile化合物 CID: 73211886Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C608887查看产品价格与包装
技术标识符
- IUPAC名称
- 6-[4-[(6-chloroimidazo[1,2-a]pyridin-2-yl)methyl]piperazin-1-yl]pyridine-3-carbonitrile
- SMILES
- N#Cc1ccc(nc1)N1CCN(CC1)Cc1cn2c(n1)ccc(c2)Cl
- InChIKey
- UGDJVSURAKMIPU-UHFFFAOYSA-N
- InChI
- 1S/C18H17ClN6/c19-15-2-4-18-22-16(13-25(18)11-15)12-23-5-7-24(8-6-23)17-3-1-14(9-20)10-21-17/h1-4,10-11,13H,5-8,12H2
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
常见问题
最后更新:2026年11月5日
应如何使用细胞增殖性疾病分类?
可用细胞增殖性疾病快速组建候选化合物集,再逐一对照各化合物的靶点页面及其活性检测方法进行核实。疾病注释反映的是已报道的关联性,而非已验证的适应症。
细胞增殖性疾病与目录其他部分是什么关系?
细胞增殖性疾病归属于按疾病分类(DOID),是按疾病注释组织的视图,其中化合物同时也收录在各自的分子靶点下。可用它快速圈定范围,再在靶点页面逐一确认。
从细胞增殖性疾病订购化合物前应核查什么?
对于细胞增殖性疾病中的任何化合物,请核查所报道活性的检测方法、种属相关性、纯度,以及推荐的母液溶剂和储存条件。批次专属数据见分析证书。所有产品仅供专业研发用途,不得用于人体、动物、诊断或治疗。
可以为细胞增殖性疾病定制化合物集吗?
细胞增殖性疾病下的化合物可按靶点、作用机制和化合物类别筛选,并可按您指定的板型提供按需挑选的化合物集。需求请提交至 compliance@aladdinsci.com。我们仅向经核实的企业、科研机构、高校和政府机构供货。
![4-[4-[3-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenyl]morpholine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/H/6/H608691.png)
![4-[6-[4-(4-methylpiperazin-1-yl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M608713.png)
![4-amino-6-{[(1S)-1-{3-methyl-6-[3-({4-[methyl(2-methylpropyl)amino]piperidin-1-yl}methyl)phenyl]-5-oxo-5H-[1,3]thiazolo[3,2-a]pyridin-7-yl}ethyl]amino}pyrimidine-5-carbonitrile](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/A/6/A608912.png)
![4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F608612.png)

![4-[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]butyl 5-[[3-[(S)-[[(3R)-1-azabicyclo[2.2.2]octan-3-yl]oxycarbonylamino]-phenylmethyl]phenoxy]methyl]-1-methylpyrazole-3-carboxylate](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/R/6/R608524.png)
![4-methoxy-3-[2-[3-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyridin-4-yl]benzonitrile](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M609349.png)
![6-(4-chlorophenyl)-3-[6-(piperidin-1-ylmethyl)naphthalen-2-yl]thieno[2,3-e]pyrimidin-4-one](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C608790.png)
![6-(4,6-Dimorpholino-1,3,5-triazin-2-yl)benzo[d]oxazol-2-amine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609025.png)
![5-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]-2-(furan-3-yl)pyridin-3-yl}-3-methyl-2H-indazole](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/S/6/S608875.png)
![6-(p-Tolyl)-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-4-amine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/P/6/P609381.png)
![6-[4-[(6-chloroimidazo[1,2-a]pyridin-2-yl)methyl]piperazin-1-yl]pyridine-3-carbonitrile](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C608887.png)
危险品化学品经营许可证(带存储)